NRX PHARMACEUTICALS - ON JULY 21, NRXD SELECTED BY DARPA FOR NEGOTIATION OF POTENTIAL SPARC-TMS CLINICAL TRIAL AWARD - SEC FILING

Reuters · 3d ago

Please log in to view news